Tim Henry (Cincinnati, USA) talks to Cardiovascular News about the initial f...
Please NOTE: This video is ONLY available to watch in selected countries and geo...
Baylis Medical has announced the publication of data demonstrating procedura...
A study published in the Journal of the American College of Cardiology (JACC) ha...
Women face a 20% increased risk of developing heart failure or dying within five...
Vectorious Medical Technologies has announced that the US Food and Drug Administ...
Philips has announced the next generation of its advanced visualisation workspac...
Gore has announced encouraging clinical results from its early feasibility study...
 Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the o...
Long-term data on the outcomes of surgery after failed transcatheter edge-to...
Data from the EXPAND G4 study, evaluating the performance of the latest gene...
Eight-year findings from the NOTION I trial—the first all-comers trial to ra...
Emerging data supports transcatheter techniques to treat primary mitral regu...
Details of an early feasibility study of transcatheter mitral edge-to-edge r...
Two-year outcomes from the MITRAL trial, presented at PCR Valves e-course (2...
One-year findings from the EXPAND registry, evaluating real-world use of new...
The first randomised trial comparing a course of pre-procedure percutaneous ...
Discussion during the first day of the PCR Valves e-course (22–24 November, ...
University of Leicester and University Hospitals of Leicester NHS Trust (UHL), L...
A study published in ACS Biomaterials Science & Engineering details the deve...
Corvia has announced completion of randomisation in its REDUCE LAP-HF II glo...
Boston Scientific has announced a global recall of all unused inventory of i...
Sinomed has announced the presentation of data from its inter-continental PI...
The volume of transcatheter aortic valve implantation (TAVI) procedures in t...
Atrial fibrillation (AF) was detected up to 10 times more frequently in high...
Among patients who stopped taking statins due to side effects, researchers f...
A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as ef...
The use of ticagrelor was not superior to clopidogrel in the reduction of th...
The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart dise...
A pooled analysis of interventional studies assessing the feasibility, effic...
Append Medical, developer of the Appligator implant-free left atrial appenda...

Michael Reardon

A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michae...
Heart valve procedures performed by cardiothoracic surgeons with 10 years of exp...
Structural racism is a major cause of poor health and premature death from heart...
Results of the Onyx One Clear study, evaluating the safety and effectiveness...
Abiomed has announced that the first 1,000 patients have been treated with the I...
A significant decline in percutaneous coronary intervention (PCI) procedures...
Payments from device manufacturers to physicians are likely to have a bearing on...
AstraZeneca’s Forxiga (dapagliflozin)—known as Farxiga—has been approved in the ...
The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing ...
MyoKardia has announced three awardees of the 2020 MyoSeeds research grant progr...
Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coro...
COVID-19 patients with a history of heart failure were associated with a longer ...
Late-breaking science in interventional cardiology is alive and well despite the...
Abiomed has announced the treatment of the first two patients using the Impella ...
Mounting evidence over the safety and efficacy of shorter-term dual antiplat...
Foldax has announced that the US Food and Drug Administration (FDA) has granted ...
The European Society of Cardiology (ESC) has announced that its full portfolio o...
BioCardia has announced the publication of data from the initial open-label roll...
A study published in the Journal of the American College of Cardiology (JACC) ha...
NOTE: This video is ONLY available to watch in selected countries and geographie...
The US Food and Drug Administration (FDA) has granted Abiomed a 510(k) clear...
Tricuspid annular dilatation (TAD) is an independent predictor of all-cause mort...
The American College of Cardiology (ACC) has published an expert consensus decis...
A research programme into understanding the underlying causes of unexplained car...
A meta-analysis of 23 randomised clinical trials comparing percutaneous coro...
Rhian E Davies (University of Washington Medical Center, Seattle, USA) discu...
The Journal of the American College of Cardiology (JACC) has issued a three-part...
Results of the OPTIMIZE IDE study, assessing the Svelte drug-eluting stent (DES)...
Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated...
CeloNova BioSciences has announced interim results from the randomised Trial...
Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–1...
One-year follow-up results of the randomised SOLVE-TAVI trial showed similar rat...
One-year clinical outcomes from the global EXPAND study, reporting on the use of...
In this issue: POPular TAVI prompts call for aspirin-only antiplatelet stra...
Shockwave Medical has announced that the coronary Investigational Device Exempti...
In this issue: POPular TAVI prompts call for aspirin-only antiplatelet stra...
Royal Philips has announced one-year results of the DEFINE PCI study, presented ...
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coro...
Interventional closure of an iatrogenic atrial septal defect (iASD) driven by tr...
The REFLECT II randomised clinical trial evaluating the safety and efficacy of a...
Findings of the SCOPE II clinical trial, which were presented during a late ...
An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (...
One in five high-risk patients undergoing major non-cardiac surgery will develop...
Cardiovascular Systems has announced the presentation of results from a larg...
Initial findings from the North American COVID-19 ST-Segment Elevation Myoca...
Medtronic has today announced a partnership with The Foundry—a medical device co...
A pilot randomised trial of percutaneous coronary intervention (PCI) of non-flow...
Medtronic has today announced plans to launch a randomised, head-to-head stu...
NuVera Medical has announced positive results from its first-in-human feasib...
LivaNova has announced new data from the Perceval Sutureless Implant Versus Stan...
The president of the European Association For Cardiothoracic Surgeons (EACTS...
“We now live in a world of wires,” commented Tom C Nguyen (chief of cardiac ...
Ahead of the first virtual edition of the Transcatheter Cardiovascular Thera...
Butterfly Network and the American College of Cardiology (ACC) have announced a ...
This article, part of an educational supplement sponsored by Siemens Healthine...
Patients with postoperative atrial fibrillation (AF) after coronary artery b...
AngelMed has announced the first implant of the next-generation AngelMed Guardia...
The European Society of Cardiology (ESC) and the European Association for Ca...
Javier Escaned (Hospital Universitario Clínico San Carlos, Madrid, Spain) discus...
An analysis of the rates and clinical implications of alternative definitions of...
Medtronic has announced that it has received US Food and Drug Administration...
Research has identified 2,085 excess deaths in England and Wales linked to cardi...
Cardiac Dimensions has closed a US$17.5 million series C financing round whi...
Boston Scientific has today announced it has initiated a controlled launch o...
InnovHeart has announced the successful first-in-human implantation of its propr...
Transcatheter aortic valve implantation (TAVI) device selection should be gu...
Over the last decade, the cath lab has transformed. Interventional cardiologists...
V-Wave has closed a Series C financing extension of up to US$98 million, assurin...
Medtronic has received Breakthrough Device Designation status from the US Food a...
After surviving a heart attack, the proportion of patients who experience a ...
Abbott has today announced it has received CE mark approval for its fourth-gener...
A study of US Medicare patients undergoing percutaneous coronary interventio...
The Cardiovascular Research Foundation (CRF) has announced that over 30 late-bre...

J Dawn Abbott

J Dawn Abbott is the director of interventional cardiology and an associate prof...
Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent...
VitalConnect has announced the commencement of the TELESTAR-TAVR clinical st...
Healthcare professionals should become more familiar with medications that c...
Cardiac magnetic resonance imaging (MRI) is effective in identifying inflamm...
Survey results published to mark Heart Valve Disease Awareness Week show that ol...
Multiple studies have shown that fractional flow reserve (FFR) is a valuable mod...
Results of the TIDES-ACS randomised controlled trial, confirming the superio...
Medtronic has announced  US Food and Drug Administration (FDA) approval of an ea...
Researchers from the University of Minnesota, with support from Medtronic, have ...
Cardiac Dimensions has announced that Australia’s Therapeutic Goods Administrati...
Fujifilm Sonosite has received 510(k) clearance from the US Food & Drug Admi...
Japan and the USA have seen an increase in percutaneous coronary intervention (P...
Concept Medical has announced the enrolment of the first patient in the TRANSFOR...
CryoLife has announced the acquisition of Ascyrus Medical, developer of the Ascy...
The American College of Cardiology (ACC) has announced that its 70th Annual Scie...
BioVentrix has announced the resumption of cases in the pivotal ALIVE Trial stud...
An invasive approach involving either percutaneous coronary intervention (PC...
According to findings of the POPular CABG trial, the addition of ticagrelor ...
Royal Philips has announced the next-generation of its Azurion image-guided ...
Miracor Medical has announced the closing of a €24 million series-E round of...
Atrial fibrillation (AF) is associated with long-term mortality in patients ...
The POPular TAVI trial has challenged current recommendations on antiplatele...
Mavacamten (MyoKardia) improves heart function and symptoms in patients with...
Transcatheter mitral valve replacement (TMVR) with the Tendyne device (Abbott) r...
The European Society of Cardiology (ESC) has issued new guidelines, published on...
Empagliflozin reduces the risk of cardiovascular death or hospitalisation for he...
Medtronic has announced that the US Food and Drug Administration (FDA) has a...
Meta analysis puts spotlight on optimal DAPT duration Cardiologists warn ...
Meta analysis puts spotlight on optimal DAPT duration Cardiologists warn ...
In this educational supplement, sponsored by Siemens Healthineers, Cardiovas...
The inaugural CX Aortic Vienna meeting will be livestreamed 8–11 September 2020 ...
Philips announced today the latest addition to its portfolio of dedicated cardio...
Guidelines for reducing the risk of stroke in patients undergoing heart surg...
The Heart Rhythm Society has announced the publication of the inaugural issue of...
The risk of in-hospital death and in-hospital heart failure increased for ST-ele...
A study comparing recommendations from a heart team versus those of an inter...
  Representation of women leading heart failure research remains lim...
Transcatheter tricuspid valve replacement in the setting of trans-tricuspid ...
Royal Philips has announced the introduction of OmniWire, a solid core pressure ...
Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking plac...
COVID-19 patients with cardiovascular comorbidities or risk factors are more lik...
Translumina has announced the publication of 10-year follow-up data on its d...
With whole sections of society migrating online during the COVID-19 pandemic...
Mental stress and anger may have clinical implications for patients with heart f...
Biosensors announced today the enrolment of the first patient in REFORM—a prospe...
A US survey released by patient advocacy group Heart-Valve-Surgery.com, with sup...
InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) syst...
The Journal of the American Heart Association (JAHA) has retracted a paper publi...
Thirty-day clinical outcomes from the FORWARD PRO international study of the...
CardioMech, developer of a transfemoral, transseptally delivered mitral valve re...
A meta-analysis of 24 randomised controlled trials assessing dual antiplatel...
Eko has announced a collaboration with AstraZeneca to accelerate the development...
The US Food and Drug Administration (FDA) has issued an emergency use author...
In this educational supplement, sponsored by Boston Scientific, Cardiovascular N...
As interventional cardiology continues to grow with higher risk patients and...
A German study of recently-recovered COVID-19 patients examined using magnetic r...
A three-year, investigator-led, prospective study of Japanese patients who r...
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (E...
Keystone Heart has announced completion of the first worldwide commercial ca...
Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart ...
The American College of Cardiology (ACC) is expanding its JACC family of peer-re...
The US Food and Drug Administration (FDA) has approved one-way digital data ...
Aortic valve replacement, using either transcatheter aortic valve implantati...
Caption Health, a developer of medical artificial intelligence (AI) technolo...
MyoKardia has announced that the US Food and Drug Administration (FDA) has grant...
Digital health and artificial intelligence (AI) company Eko has been awarded a U...
Genetic testing and counselling for inherited cardiovascular diseases may he...
Findings of a US investigation of clinician race and gender bias in decision...
Scitech has announced that the Inspiron coronary sirolimus eluting stent has rec...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
LifeSignals Group has announced that it has received US Food and Drug Administra...
Azeem Latib (New York, USA) spoke to Cardiovascular News about a sub-analysi...
  Philipp Lurz (Leipzig, Germany) speaks to Cardiovascular News abou...
LivaNova has announced that the advanced Perceval Plus sutureless surgical aorti...
Women taking beta blockers for hypertension with no prior history of cardiovascu...
A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with ...
Edwards Lifesciences has announced approval from the US Food and Drug Admini...
The American Heart Association (AHA) has announced that its 2020 Scientific Sess...
Around half of COVID-19 patients who received an echocardiogram in-hospital show...
Revamp Medical has announced that the US Food and Drug Administration (FDA) has ...
ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rap...
Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex tec...
The European Association of Percutaneous Cardiovascular Interventions (EAPCI...
Janarthanan Sathanathan (Center for Heart Valve Innovation, St Paul’s Hospit...
Paragonix Technologies presented new clinical data at the American Transplant Co...
MedAlliance has announced enrollment of the first patient in its study of Se...
Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News abou...
Black patients who undergo percutaneous coronary intervention (PCI) are at an ...
Ancora Heart has been given US Food and Drug Administration (FDA) approval o...
The American Heart Association (AHA) has named Mitchell SV Elkind as preside...
Using an Impella device is contraindicated in patients with severe aortic st...
NuVera Medical has announced the initiation of the company's first-in-human ...
US national hospital- and surgeon-level inverse volume–outcome associations ...
Patients who have trouble sleeping after heart bypass surgery should go for a ...
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE)...
Mid-term data continue to show non-inferiority of resting instantaneous wave...
A subanalysis of the Onyx One study found that cardiac death was significant...
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) d...
MedAlliance has been awarded CE mark for the Selution SLR 014 percutaneous trans...
BioCardia has announced that it has resumed cases in the CardiAMP Heart Fail...
The feasibility, safety, and efficiency of transcatheter aortic valve implan...
According to a press release, one-year total population clinical outcome dat...
The FABOLUS FASTER trial, which was presented at PCR e-Course 2020 and simul...
Felice Gragnano (Inselspital, Bern University Hospital, Bern, Switzerland) o...
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ...
Sripal Bangalore (New York University Grossman School of Medicine, New York,...
One-year results from the TRILUMINATE study show that TriClip (Abbott) trans...
Clinical and imaging results at 12 months for the DynamX Novolimus-Eluting C...
A systematic two-stent approach in complex coronary bifurcation lesions is a...
Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO...
Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findin...
Long-term clinical outcomes, including mortality, following an aortic valve-...
Use of the transseptal Evoque transmitral valve replacement (TMVR) system (E...
A comprehensive evaluation of mitral valve-in-valve (ViV) and valve-in-ring ...
The American College of Cardiology (ACC) and Society for Vascular Surgery (S...
Miracor Medical has announced the award of the CE mark for its latest genera...
Medtronic has been awarded CE mark for the use of the Evolut transcatheter a...
Voice analysis by a smartphone app can identify lung congestion in heart failure...
Proximo Medical has announced a partnership with digital health company Coal...
Abiomed has launched a virtual physician education programme, CAMP PCI (Coro...
Trainee interventional cardiologists have raised concerns that reductions in...
Telemedicine has come into its own during the pandemic. Sameer Mehta details...
Blue Sail Medical has completed the acquisition of Swiss based company NVT A...
MicroPort has been given CE approval for its PathBuilder Steerable Introduce...
The British Heart Foundation (BHF) is calling on the Government and the NHS ...
Abiomed has received investigational device exemption (IDE) from the US Food...
Biosensors International Group has announced the appointment of Keith G Oldr...
Collaboration between cardiothoracic and vascular surgeons is key to achievi...
Medtronic has received the CE mark for a one-month dual antiplatelet therapy...
Clinical and echocardiographic outcomes at 30 days and one year were similar...

Vinod Thourani

Mitral and tricuspid valve technologies, aortic valve replacement, and the v...
The American College of Cardiology (ACC) is to host a weekly virtual meeting...
The European Society of Cardiology (ESC) has announced that the HFA Discoveries ...
COVID-19 linked to a near 40% drop in STEMI cases in US cath labs Survey ...
COVID-19 linked to a near 40% drop in STEMI cases in US cath labs Survey ...
A Bayesian analysis of EXCEL and other randomised controlled trials comparing co...
LivaNova have presented the first data from the Perceval sutureless implant ...
CeloNova BioSciences has announced that it has successfully completed enrolmen...
The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting has become th...
The Society for Cardiovascular Angiography and Interventions (SCAI) and the ...
According to research published in JACC: Heart Failure, patients with heart ...
A press release reports that the Society of Cardiovascular Computed Tomograp...
According to a survey published in the Journal of Occupational and Environme...
In JACC: Heart Failure, Mathias Orban (Medizinische Klinik und Poliklinik I,...
Several studies have suggested that, across all countries, COVID-19 mortalit...
Data from more than 1,000 patients presented during the virtual Society for ...
Medtronic has that announced Jeffrey J Popma (Harvard Medical School; Beth Israe...
Edwards Lifesciences has received the CE mark for the PASCAL transcatheter v...
A study published in Circulation: Cardiovascular Interventions shows that ro...
A late-breaking clinical trial presented at the virtual Society for Cardiova...
Weili Xu (Department of Epidemiology and Biostatistics, School of Public Hea...
A study presented at the virtual Society for Cardiovascular Angiography and ...
A study presented yesterday at the virtual Society for Cardiovascular Angiog...
A novel, groundbreaking trial has examined the viability of telemedicine for r...
PCR has announced a new online initiative—e-Course 2020—that is to run onlin...
The Society for Cardiovascular Angiography and Interventions (SCAI) has publ...
MedAlliance has announced the award of its second CE mark: Selution SLR 014 ...
A survey published in The Annals of Thoracic Surgery find that despite being...
The American College of Cardiology (ACC) is start to collecting COVID-19 dat...
Royal Philips has announced that it has received 510(k) clearance from the U...
The US Food and Drug Administration (FDA) has expedited clearance of an upda...
Two-year data from the BIONYX trial show that all-comer patients who underwe...
According to a statement, Heart Valve Voice US is “deeply concerned” that the pa...
A joint UK-US research team is applying an artificial intelligence (AI) system t...
BioCardia has announced data from a recent animal study performed that, acco...
Corresponding author Valentin Fuster (Mount Sinai Heart, New York, USA) and ...
Boston Scientific has announced positive 12-month results from the PINNACLE ...
  A BIBA MedTech Insights survey indicates that 50% of centres perfo...
Vishal Luther (final year cardiology registrar/ Electrophysiology fellow, Im...
The European Society of Cardiology (ESC) is, for the first time in its 70-ye...
According to recently presented TICO trial data, a press release reports, pa...
ZOLL Medical has received CE Mark approval to market and distribute its Supe...
The Society of Cardiovascular Computed Tomography (SCCT) has announced plans...
The American College of Cardiology (ACC) and other North American cardiology...
A study presented at EAPC Essentials 4 You—a virtual scientific platform of ...
LifeSignals has received CE mark approval for the LifeSignals ECG Remote Mon...
A necklace that detects abnormal heart rhythm will be showcased for the firs...
PCR has issued a statement announcing that it is officially cancelling the 2...
Recent studies have suggested that during the pandemic, there has been a dro...
A new study has found no significant differences in hospital mortality betwe...
Before the 1940s, the prognosis for babies born with complex congenital hear...
Prism Schneider (Cumming School of Medicine, University of Calgary, Calgary,...
Abiomed (maker of the Impella heart pump) has acquired Breethe, developer of...
New guidance from the American Academy of Neurology (AAN) recommends the clo...
On 18 March, the Centers for Medicare & Medicaid Services (CMS) recommen...
Robocath, which designs, develops and commercialises cardiovascular robotic ...
iRhythm Technologies has announced a virtual platform to support patients an...
Boston Scientific, according to a press release announcing the company’s Q1 ...
The Society for Cardiovascular Angiography and Interventions (SCAI) and Canadian...
A press release reports that the British Heart Foundation (BHF) and the Nati...
VisCardia has been granted Breakthrough Device Designation from the US Food ...
LivaNova has announced that several of its cardiopulmonary products are can ...
In the Journal of American College of Cardiology, Ehtisham Mahmud (Universit...
A press release reports that several of the world’s ventilator manufacturers hav...
New data suggest that a medical device that uses vitamin B2 and ultraviolet ligh...
Pi-Cardia has closed a US$27 million round of financing, led by Sofinnova Pa...
Proximo Medical has announced a partnership with Elucid Bioimaging, a develo...
Studies have shown that robotic percutaneous coronary intervention (PCI) wit...
In response to a recent American College of Cardiology (ACC) review that adv...
In the first of a series of webinars focusing on COVID-19, Society for Cardi...
The COVID-19 pandemic is hitting the world hard. Egypt, the most populous co...
Impulse Dynamics has announced the publication of the FIX-HF-5C2 study in Ci...
Enrique Ostrzega (University of Southern California, Los Angeles, USA) and c...
The US Food and Drug Administration (FDA) issued an emergency use authorisat...
Santiago Garcia (Minneapolis Heart Institute Foundation, Abbott Northwestern...
The American Heart Association (AHA) has compiled interim CPR guidelines to ...
In a brief report in Annals of Internal Medicine, Seongman Bae (Asan Medical...
Physicians recognised the importance of remote management for heart failure ...
In separate statements, the European Society of Cardiology (ESC) and America...
Abbott has received the CE mark for its TriClip transcatheter tricuspid valv...
Presidents of leading cardiac organisations, including the American Heart Associ...
Royal Philips has announced that the US government and Philips agreed to team up...
Mardil Medical has announced the successful completion of treatment for the ...
Shockwave Medical has completed enrolment in its US Food and Drug Administra...
Ahmed Bendary describes the findings of a meta-analysis published last month...
A soft robotic heart that is designed to replace the need for a heart transp...
At the 2019 European Association of Cardio-Thoracic Surgeons (EACTS) annual ...
Cardiovascular specialists from across the globe shared current knowledge an...
The American Heart Association (AHA), in conjunction with the American Assoc...
The reduced levels of angiotensin converting enzyme (ACE) 2 associated with card...
Edwards Lifesciences has temporarily paused new enrolments in its active piv...
The European Commission (EC) has adopted a proposal to postpone by one year ...
Athena Poppas (Providence, USA) is the new president of the American College...
Simon Ray, president of the British Cardiovascular Society (BCS), has told t...
In a new statement published on 2 April 2020, all 45 societies represented by th...
A raised troponin level in myocardial injury “greatly alters the prognosis adver...
The COVID-19 Cardiovascular Conference, hosted as a live webinar by The Impe...
Cardiologists from across Europe have shared their experience of having treated ...
The American College of Surgeons (ACS) today leapt to the defense of healthc...
Daniel M Philbin Jr has been named chair of the American College of Cardiolo...
The Imperial College Network of Excellence in Vascular Science at Imperial Colle...
According to Geu-Ru Hong (Division of Cardiology, Severance Cardiovascular H...
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the Ameri...
The longest follow-up to date of patients with left main coronary artery dis...
Today at the American College of Cardiology/World Congress of Cardiology’s v...
Using the radial artery instead of the saphenous vein for patients undergoin...
Medtronic today announced positive results of the Onyx ONE Clear Study that ...
“More bleeding with background clopidogrel, even if not severe by adjudicati...
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of...
Three months after undergoing renal denervation, patients with untreated hig...
Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appen...
In the POPULAR TAVI trial, patients with atrial fibrillation who took oral a...
During the first Featured Clinical Research session of the virtual American ...
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provide...
Treatment with aspirin plus rivaroxaban following lower extremity revascular...
Today, during the Virtual American College of Cardiology (ACC) event (28–30 ...
During a Q&A section of a European Commission (EC) college meeting on 25...
A viewpoint in the Journal of the American Medical Association (JAMA) has of...
Cardiac injury is common among hospitalised patients with COVID-19, and is assoc...
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological ...
The American Heart Association (AHA) has committed US$2.5 million to research ef...
The British Cardiovascular Intervention Society (BCIS) and the British Cardi...
The Society for Cardiology and Angiography Interventions (SCAI) has set up a...
CroíValve has announced the successful first human use of its Duo Tricuspid ...
A new Heart & Stroke guideline published today in the Canadian Medical Assoc...
A case series of US experience with COVID-19 has upheld suggestions of a link wi...
The US Food and Drug Administration (FDA) has issued an immediately-in-effec...
The first report on the impact of COVID-19 on heart transplant recipients ha...
Frailty is an independent predictor of morbidity, death, and increased costs aft...
The Society for Cardiovascular Angiography and Interventions (SCAI) has writ...
Data from a pilot imaging study of commissural alignment in trancatheter aor...
European CE mark has been awarded to the TriGUARD 3 cerebral embolic protect...
Portola Pharmaceuticals announced new data that they say reinforces the value of...
Early improvement in health status for patients in the COAPT trial who had t...
Patients who have a percutaneous coronary intervention (PCI) for chronic tot...
The novel left atrial appendage (LAA) closure device Appligator (Append Medi...
Abbott made history in January when it became the first company in the world...
The American College of Cardiology Scientific Session Together with World Congre...
Vascular remodelling may occur in response to sustained, regular exercise, sugge...
Abbott has received CE mark in Europe for the new FlexNav delivery system fo...
The New England Journal of Medicine (NEJM) has launched a review into the data f...
A short film (“Today is a Good Day”), which showcases the work of Aortic Dis...
NOTE: This video is ONLY available to watch in selected countries and geographie...
NOBLE finds PCI inferior to CABG at five years in left main disease EXCEL...
NOBLE finds PCI inferior to CABG at five years in left main disease EXCEL...
Paclitaxel drug coated balloons (DCB) for percutaneous treatment of coronary...
Findings from an interim analysis of PROTECT III have added to the evidence ...
CryoLife has received CE mark for the On-X Ascending Aortic Prosthesis (AAP)...
The US Food and Drug Administration (FDA) has cleared a new version of the LivaN...
Endotronix has announced the enrollment of the first two patients in the PRO...
A research project at the University of Leeds aiming to identify new drug tr...
Transcatheter aortic valve implantation (TAVI) is safe in the short term in ...
Patients who develop stage 3 acute kidney injury (AKI) following transcathet...
Biotronik has announced three-year data from the BIOFLOW-V trial, which were...
Append Medical, developer of the Appligator, a novel left atrial appendage (...
Edwards Lifesciences has announced a new goal for its philanthropic initiative, ...
A comparison of newer generation self-expanding valves (SEV) and balloon-exp...
Ablative Solutions has revealed that positive six-month results from the Per...
Cardiovalve has received US Food and Drug Administration (FDA) approval for ...
Last month, Abbott announced US Food and Drug Administration (FDA) approval ...
The news programme BBC Newsnight has made further claims that the EXCEL inve...
VitalConnect has announced the introduction of arrhythmia detection to its r...
Gregg W Stone (Icahn School of Medicine, Mount Sinai, New York, USA) address...
Nicolas van Mieghem

Nicolas van Mieghem

Nicolas van Mieghem (professor of interventional cardiology, department of c...
The US Food and Drug Administration (FDA) has authorised marketing of software t...
Orsiro Mission DES

Orsiro Mission gets CE mark

Biotronik has received CE mark certification for the Orsiro Mission drug-elu...
Philips has announced a new randomised controlled trial to assess percutaneo...
Scott Lim (Charlottesville, USA) talks to BLearning Cardio at PCR London Val...
 Philippe Pibarot (Québec, Canada) talks to BLearning Cardio at PCR London V...
BioVentrix has received renewal of the highest priority reimbursement in Germa...
Extended 10-year follow-up has demonstrated that in patients with a high SYN...
The debate over the results of EXCEL shows no sign of abating, and there see...
Medtronic has announced that it will begin enrolment in a pilot study evaluating...
The US Food and Drug Administration (FDA) has granted Breakthrough Device De...
Rajiv Patni has been appointed as executive vice president and chief medical...
 Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19...
Guy’s and St Thomas’ and Royal Brompton & Harefield NHS Foundation Trusts ar...